127 related articles for article (PubMed ID: 7086612)
1. Growth hormone--dependent growth failure.
Frazer T; Gavin JR; Daughaday WH; Hillman RE; Weldon VV
J Pediatr; 1982 Jul; 101(1):12-5. PubMed ID: 7086612
[TBL] [Abstract][Full Text] [Related]
2. Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay.
Kemp SF; Rosenfeld RG; Liu F; Gaspich S; Hintz RL
J Clin Endocrinol Metab; 1981 Apr; 52(4):616-21. PubMed ID: 7204536
[TBL] [Abstract][Full Text] [Related]
3. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
[TBL] [Abstract][Full Text] [Related]
4. Growth failure with plasma GH that is normal by RIA but low by radioreceptor assay: responsiveness to exogenous GH.
Bistritzer T; Chalew SA; Kowarski AA
Horm Res; 1995; 43(6):261-5. PubMed ID: 7607611
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
LaFranchi S; Hanna CE; Jelen B
Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
[TBL] [Abstract][Full Text] [Related]
6. Somatomedin levels in the diagnosis and therapy of growth hormone deficiency.
Giannella-Neto D; Wajchenberg BL; Mendonca BB; Liberman B; Nery M; Macchione M; Spencer EM
Horm Metab Res; 1988 Mar; 20(3):175-81. PubMed ID: 3384400
[TBL] [Abstract][Full Text] [Related]
7. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.
Kowarski AA; Schneider J; Ben-Galim E; Weldon VV; Daughaday WH
J Clin Endocrinol Metab; 1978 Aug; 47(2):461-4. PubMed ID: 263308
[TBL] [Abstract][Full Text] [Related]
8. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
[TBL] [Abstract][Full Text] [Related]
9. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
Grunt JA; Howard CP; Daughaday WH
Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
[TBL] [Abstract][Full Text] [Related]
10. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children.
Bozzola M; Cisternino M; Biscaldi I; Maghnie M; Valtorta A; Moretta A; Severi F
Eur J Pediatr; 1988 Apr; 147(3):248-51. PubMed ID: 3292246
[TBL] [Abstract][Full Text] [Related]
12. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
14. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
Rappaport R; Prevot C; Brauner R
J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
[TBL] [Abstract][Full Text] [Related]
15. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
Rogol AD; Blizzard RM; Johanson AJ; Furlanetto RW; Evans WS; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
[TBL] [Abstract][Full Text] [Related]
17. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Short-term effects.
Wit JM; Van den Brande JL
Horm Res; 1984; 19(4):205-15. PubMed ID: 6745841
[TBL] [Abstract][Full Text] [Related]
18. A partial transient effect of short-term growth hormone (GH) treatment in short non-GH deficient prepubertal children.
Low LC; Kwan E; Karlberg J
J Pediatr Endocrinol Metab; 1995; 8(3):173-9. PubMed ID: 8521191
[TBL] [Abstract][Full Text] [Related]
19. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
20. Somatomedin and growth hormone studies in pediatric renal allograft recipients who receive daily prednisone.
Pennisi AJ; Costin G; Phillips LS; Malekzadeh MM; Uittenbogaart C; Ettenger RB; Fine RN
Am J Dis Child; 1979 Sep; 133(9):950-4. PubMed ID: 224694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
